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Original Article 
 
 
Non-Diabetic Renal Disease in Patients with Type-2 Diabetes Mellitus 
 
Sonia Yaqub, Waqar Kashif, Syed Ather Hussain 
 
Section of Nephrology, Department of Medicine, Aga Khan University Hospital, Karachi, 
Pakistan 
 
ABSTRACT. Diabetic nephropathy (DN) is the leading cause of end-stage renal disease in diabetics 
worldwide, yet most patients with type-2 diabetes mellitus are not formally evaluated with a renal biopsy. 
The diagnosis is almost always based on clinical grounds. A wide spectrum of non-diabetic renal disease 
(NDRD) is reported to occur in patients with type-2 diabetes. It has been estimated that up to one-third of 
all diabetic patients who present with proteinuria are suffering from NDRD. The aim of this analysis was to 
evaluate the prevalence and etiology of NDRD in patients with type-2 diabetes. We retrospectively reviewed 
the medical records of patients with type-2 diabetes who underwent kidney biopsy on clinical suspicion of 
NDRD (absence of diabetic retinopathy and/or neuropathy; short duration of diabetes, i.e. less than five 
years) from January 2003 through December 2007 at the Aga Khan University Hospital, Karachi. Based on 
the biopsy findings, patients were grouped as Group-I, isolated NDRD; Group-II, NDRD with underlying 
DN; and Group-III, isolated DN. Of 68 patients studied, 75% were males and the mean age was 56 years. 
The mean duration of diabetes was nine years. Group-I included 34 patients (52%), Group-II included 11 
patients (17%) and Group-III included 23 patients (31%). Among the Group-I patients, the mean age was 
56 years (41–77 years). The most common NDRDs were acute interstitial nephritis (32%), diffuse prolife-
rative glomerulonephritis (17%); membranous nephropathy (12%) and crescentic glomerulonephritis (12%). 
Among Group-II, the mean age was 60 years (46–71 years), and the most common lesion was interstitial 
nephritis superimposed on underlying DN (63% cases). Among Group-III, the mean age was 53 years (42–
80 years). The mean proteinuria was 5, 6.3 and 7.3 g/24 h of urine collection in Groups I, II and III, respec-
tively (P = NS). The mean duration of diabetes was 7.3, 11.7 and 10.7 years in Groups I, II and III, respec-
tively. The duration of diabetes was significantly less in Group-I compared with Group-II and Group-III (P = 
0.04). Our study suggests that the prevalence of NDRD (either isolated or superimposed on underlying DN) 
is high in appropriate clinical settings. Performing renal biopsy in diabetics with no extrarenal end organ 
damage other than nephropathy helps to diagnose and treat NDRD. This is the first report from Pakistan 
documenting the prevalence of NDRD in patients with type-2 diabetes. 
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Introduction 
 
  The incidence and prevalence of diabetes 
mellitus are on the rise worldwide.1 Nearly 21 
million people in the United States (7% of the 
population) have diabetes, and about one-third 
of those with diabetes are unaware of their con-
dition.2 Worldwide, 171 million people have 
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diabetes.2 It is projected that in the US popu-
lation, the prevalence of diabetes will increase 
by 165% between 2000 and 2050, with the 
greatest increase being in older individuals 
(>75 years) and among African Americans.3 
The global burden of diabetes is expected to 
double between 2000 and 2030, with the grea-
test increase in prevalence occurring in the 
Middle East, Sub-Saharan Africa and India.2 
This is attributed to the progressive demo-
graphic transition worldwide with urbanization 
along with increased and prolonged exposure 
of the ageing population to unhealthy lifestyles, 
including a calorie-dense diet and physical in-
activity.4 
  Diabetic nephropathy (DN), one of the com-
plications of diabetes, has been the leading 
cause of end-stage renal disease (ESRD) in 
developed countries, and has been increasing 
rapidly in many developing countries.5,6 Accor-
ding to the United States Renal Dialysis Re-
gistry System (USRDS) 2006 Report, DN is 
the primary cause of kidney failure in appro-
ximately 45% of the patients receiving dialysis 
therapy.7 Moreover, 15–23% of the patients 
with diabetes are estimated to have advanced 
stages (moderate to severe) of chronic kidney 
disease.8,9 
  But, this story is not simple because all renal 
diseases that occur in diabetic patients need 
not always be DN. It has been estimated that 
up to one-third of diabetic patients who pre-
sent with proteinuria are suffering from non-
diabetic renal diseases (NDRD).10-14 The usual 
criteria for suspecting NDRD and performing 
kidney biopsy in patients with type-1 diabetes 
are presence of microscopic hematuria, absence 
of diabetic retinopathy, uncharacteristic change 
in kidney function or presence of other syste-
mic diseases.15 However, the validity of these 
clinical conditions is not well established for 
patients with type-2 diabetes. The occurrence 
of isolated NDRD or with concurrent DN has 
important implications for therapy and progno-
sis as DN is hard to reverse, but some NDRD 
are often treatable and even remittable. 
  The prevalence of NDRD in patients with type-
2 diabetes has been variably reported in the 
published literature. Studies from India have 
reported the prevalence of NDRD to vary from 
12% to 72.5%.16 The prevalence and nature of 
NDRD in patients with type-2 diabetes is not 
documented in Pakistan. 
  The aim of this study is to assess the pre-
valence and to study the etiology of NDRD 
and correlate it with clinical parameters such 
as duration of diabetes, amount of proteinuria 
and microscopic hematuria at a tertiary care 
hospital in Pakistan. 
 
Materials and Methods 
 
  We retrospectively reviewed the medical re-
cords of patients who underwent kidney biopsy 
from January 2003 through December 2007 at 
our institute, The Aga Khan University Hos-
pital. Of 273 patients who had undergone renal 
biopsy, 68 had type-2 diabetes and were biop-
sied on clinical suspicion of NDRD. 
  The indications for renal biopsy in the dia-
betic patients included the following: 
• Nephrotic range proteinuria or renal im-
pairment (serum creatinine ≥1.5 mg/dL) in 
the absence of diabetic retinopathy 
• Nephrotic range proteinuria or renal im-
pairment (serum creatinine ≥1.5 mg/dL) 
with duration of diabetes shorter than five 
years 
• Unexplained microscopic hematuria, defined 
as more than three red blood cells per high 
power field in a centrifuged urine sample 
• Unexplained acute kidney injury, defined 
as unexplained rise in serum creatinine 
≥0.5 mg/dL in a patient with previously 
normal kidney function 
• Rapidly declining renal function in patients 
with previously stable renal function 
• Sudden onset of nephrotic range protei-
nuria with normal kidney function. 
  Patients with ESRD were excluded. The 
biopsy material was processed for light micros-
copy and immunofluorescence. DN was diag-
nosed by an experienced renal pathologist by 
the presence of mesangial expansion and dif-
fuse inter-capillary glomerulosclerosis, with or 
without the nodular Kimmelstiel–Wilson for-
mation, basement membrane thickening, fibrin 
caps or capsular drops. 
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  Based on the biopsy findings, the patients  
were categorized as follows: 
Group-I: Isolated NDRD 
Group-II: NDRD superimposed on underlying 
DN 
Group-III: Isolated DN 
  Clinical details including age, gender, dura-
tion of diabetes, presence or absence of hyper-
tension, presence or absence of diabetic retino-
pathy and indication for biopsy were recorded 
from the case records. The laboratory profile 
noted included blood urea nitrogen (BUN), 
serum creatinine, urinalysis and degree of pro-
teinuria either by 24-h urine collection or by 
spot urine protein to creatinine ratio. 
 
Definitions 
  The duration of diabetes was defined as the 
period between the age at onset and age at per-
forming renal biopsy. Hypertension was defined 
as blood pressure more than 140/90 mmHg 
with or without antihypertensives. Diabetic 
retinopathy was diagnosed on fundoscopy by 
an ophthalmologist; diagnostic findings in-
cluded presence of background retinopathy 
(microaneurysms, hemorrhages, soft exudates, 
hard exudates) with or without proliferative 
changes. 
 
Statistical Analysis 
 
  Correlation of histological findings with clin-
ical and biochemical parameters was carried 
out. Collected data were analyzed using SPSS 
for windows version 15. Data are expressed as 
mean ± SD. Differences between groups were 
assessed by using the univariate chi-square test 
for categorical variables, unpaired t-test or 
ANOVA for continuous variables where appro-
priate; P <0.05 was considered statistically 
significant. 
 
Results 
 
  A total of 68 patients with type-2 diabetes 
underwent renal biopsy during the study pe-
riod. Thirty-four patients (52%) belonged to 
Group-I (isolated NDRD), 11 (17%) to Group-II 
(NDRD with underlying DN) and 23 (31%) to  
 
 
 
Figure 1. Group frequencies among the study 
patients. 
 
Group-III (isolated DN) (Figure 1). Clinical and 
laboratory parameters in the three groups are 
shown in Table 1. Males outnumbered females 
in all the groups. The duration of diabetes was 
significantly less in Group-I than in Group-II 
and Group-III (P = 0.04). The prevalence of 
hypertension was similar in all three groups. 
Level of proteinuria was higher in Group-II 
and Group-III when compared with Group-I, 
but the difference was not statistically signi-
ficant. The serum creatinine levels were signi-
ficantly higher in Group-II and Group-III (P 
<0.0001). The incidence of microscopic hema-
turia was not different among the three groups. 
  Indications for renal biopsy included rapidly 
declining renal function in 31 patients (45.5%), 
absence of diabetic retinopathy in 12 patients 
(17.6%), unexplained acute kidney injury in 12 
patients (17.6%) and duration of diabetes 
mellitus less than five years in nine patients 
(13.2%), and miscellaneous in eight others 
(Table 2). 
  The histological lesions identified in patients 
in Group-I and Group-II are presented in Table 
3. Among Group-I patients, the most common 
NDRD were acute interstitial nephritis (AIN) 
(32%), diffuse proliferative glomerulonephritis 
(20.5%); membranous nephropathy (12%) and 
crescentic glomerulonephritis (12%), while 
Group-II predominantly comprised AIN (63%). 
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Discussion 
 
  DN is one of the most frequent and clinically 
important complications of diabetes mellitus. 
It affects approximately 40% of the patients 
who have had diabetes for more than 20 years 
and has become the leading cause of ESRD 
worldwide.5,6,17 
  The diagnosis of DN is almost always based 
on clinical grounds and is supported by a long 
history of diabetes, evidence of target organ 
damage and proteinuria preceding azotemia. 
However, DN is not the only renal disease in 
diabetes. Many NDRD have been uncovered 
by renal biopsy. It has been shown that renal 
disease in patients suffering from type-1 dia-
betes for more than 10 years, especially in the 
presence of diabetic retinopathy or neuropathy, 
is usually the result of DN, and it has been 
proven histologically in >95% of the patients. 
But, this is not the case in patients with type-2  
 
diabetes.18-20 Kidney biopsies from patients 
with type-2 diabetes, with renal disease or pro-
teinuria, show that they comprise a more hetero-
geneous group of renal lesions other than 
DN.10-13,16,21-28 
  Different predicting factors have been iden-
tified in diabetic patients found to have NDRD, 
including late onset of diabetes, absence of 
neuropathy/retinopathy, abrupt onset or prog-
ression of renal disease (massive proteinuria or 
renal insufficiency) and presence of micros-
copic hematuria.27,29-31 
  Among patients with type-2 diabetes who had 
renal biopsy, the prevalence of NDRD varies 
widely in the published literature, from 12% to 
79%, depending on the selection criteria and 
the population being studied.10-13,16,21-28,32-34 In 
our study, all patients had type-2 diabetes, and 
69% of the patients had NDRD (either isolated 
or superimposed on underlying DN). 
  We found a predominance of males in all three  
Table 1. Clinical and laboratory parameters in the different groups of patients studied. 
Parameters Total n = 68 
Group-I 
n = 34 
(NDRD) 
Group-II 
n = 11 
(NDRD + DN) 
Group-III 
n = 23 
(DN) 
P-value 
Age at biopsy (years) 56 ± 8 56 ± 9 60 ± 8 53 ± 9 NS 
Gender (M/F) 51/17 20/14 10/1 21/2  
Duration of diabetes (years) 9 (SD 6.8) 7.3 (SD 7) 11.7 (SD 10) 10.7 (SD 10) 0.04 
Hypertension (%) 89.7 75.7 91.6 100 NS 
Mean serum creatinine 
(mg/dL) 4.5 (SD 2.56) 3.45 (SD 1.9) 5.1 (SD 2.1) 5.4 (SD 3) <0.0001 
Proteinuria (g/24 h)  5 (0.3–20) 6.3 (2–10) 7.3 (1–13) NS 
Microhematuria (%) 51.4 60.6 41.6 34.7 NS 
NDRD: non-diabetic renal disease, DN: diabetic nephropathy 
Table 2. Indications for kidney biopsy in the study patients. 
Indications 
Total 
(n = 68) 
n (%) 
Group-I 
(Isolated NDRD) 
(n = 34) n (%) 
Group-II 
(NDRD + DN) 
(n = 11) n (%) 
Group-III 
(Isolated DN) (n 
= 23) n (%) 
Rapidly declining renal function in 
patients with previously stable renal 
function 
31 (45.5) 10 (30.3) 8 (66.6) 13 (56.2) 
Heavy proteinuria or renal impairment 
in the absence of diabetic retinopathy 12 (17.6) 5 (15.1) 2 (16.6) 5 (21.7) 
Unexplained acute renal failure 12 (17.6) 10 (30.3) Nil 2 (8.6) 
Heavy proteinuria or renal impairment 
with duration of diabetes mellitus less 
than five years 
9 (13.2) 5 (15.1) 2 (16.6) 2 (8.6) 
Unexplained microscopic hematuria 3 (4.4) 3 (9.0) Nil Nil 
Heavy proteinuria 1 (1.4) Nil Nil 1 (4.3) 
NDRD: non-diabetic renal disease, DN: diabetic nephropathy 
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three groups. It was found that patients with 
isolated DN were younger than patients with 
NDRD (either isolated or mixed disease). The 
duration of diabetes was significantly less in 
the isolated NDRD group compared with the 
other groups. Thus, shorter duration of diabe-
tes and older age could be risk factors for 
NDRD. Lee et al also concluded that a shorter 
duration of diabetes was significantly asso-
ciated with NDRD.23 Similar results were re-
ported by Wong, Tone and Huang et al.14,28,35 
Soni et al from India also reported that a short 
duration of diabetes was a predictor of 
NDRD.16 However, Bertani et al and Mak et al 
found no significant difference in the duration 
of diabetes among the different groups.24,36 
The prevalence of hypertension was similar in 
all three groups in our study, which is con-
sistent with the findings reported by Soni and 
Matias et al.16,37 
  We found that patients with isolated DN as 
well as those with mixed disease tended to 
have higher levels of proteinuria compared 
with the group with isolated NDRD; the dif-
ference did not achieve statistical significance. 
Lin et al also reported lower proteinuria in 
patients with NDRD thus making it a signi-
ficant factor indicative of renal biopsy.32 Mak 
et al found that patients with isolated DN had a 
higher degree of proteinuria when compared 
with those with NDRD.24 
  In this study, the serum creatinine levels were  
 
significantly higher in patients with DN (iso-
lated as well as with superimposed disease) 
compared with those with NDRD (P <0.0001). 
Similar results were reported by Matias et al 
while Soni et al showed that the degree of azo-
temia was higher in patients having super-
imposed NDRD.16,37 Taft et al reported that in 
patients with DN, co-existing renal disease was 
found to be associated with a significantly 
higher creatinine level, independent of the se-
verity of DN.38 Mak and Lin et al found that 
patients with both isolated DN and NDRD did 
not have any difference in serum creatinine 
levels.24,32 
  The presence of microscopic hematuria has 
been suggested by different authors to be one 
of the atypical features indicating presence of 
NDRD. Mak and Matias et al found a strong 
correlation between NDRD and microscopic 
hematuria.24,37 On the contrary, Serra et al re-
ported that DN was most commonly found in 
diabetic patients manifesting microscopic he-
maturia.15 In our study, there was no difference 
in the prevalence of microscopic hematuria 
among the three groups. Other authors also 
found that the frequency of microscopic hema-
turia was similar in those with DN and NDRD 
(isolated and superimposed).16,32 A Japanese 
study by Tone showed that microscopic hema-
turia had lower sensitivity and specificity for 
the prediction of NDRD compared with the 
other parameters, suggesting that microscopic  
Table 3. Histological diagnosis in patients in Group-I and Group-II. 
Histology Group-I (n = 34) 
(Isolated NDRD) 
n (%) 
Group-II (n = 11) 
(NDRD superimposed on 
underlying DN) n (%) 
Acute interstitial nephritis 11 (32.3) 7 (63.6) 
Diffuse proliferative glomerulonephritis 
(post-infectious) 7 (20.5) - 
Membranous nephropathy 4 (11.7) - 
Crescentic glomerulonephritis 4 (11.7) - 
Minimal change disease 2 (5.8) - 
Focal and segmental glomerulosclerosis 2 (5.8) - 
IgA nephropathy 2 (5.8) - 
Amyloidosis 1 (2.9) - 
Lupus nephritis 1 (2.9) - 
Membranoproliferative glomerulonephritis - 1 (9) 
End-stage renal disease - 3 (27.2) 
NDRD: non-diabetic renal disease, DN: diabetic nephropathy 
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hematuria is not a good predictor of NDRD.28 
  Absence of diabetic retinopathy is said to be 
one of the important predictors of NDRD. In 
people with type-1 diabetes, the association is 
stronger than in those with type-2 diabetes. 
This correlation has been reported by Lee et al, 
who showed that absence of retinopathy was 
one of the significant factors that predicts 
NDRD.23 Tone et al reported that absence of 
retinopathy showed the highest sensitivity 
(87%) and specificity (93%) for the prediction 
of NDRD.28 Similar findings have been repor-
ted by others.16,26,37 Wong et al showed that 
absence of retinopathy with hematuria and/or 
proteinuria ≥2 g/day constitutes the most sen-
sitive marker for NDRD and is thus a strong 
indication for biopsy.14 However, a few studies 
have demonstrated lack of correlation between 
NDRD and presence of retinopathy.24,32 
  Histologically, NDRD comprised a heteroge-
neous group in our study. In Group-I patients 
(isolated NDRD), the most common NDRD 
was AIN, followed by diffuse proliferative 
glomerulonephritis, membranous nephropathy 
and crescentic glomerulonephritis (Table 3). 
Among Group-II patients also (mixed disorder 
DN plus NDRD), AIN was the most common 
lesion. Thus, AIN was the most frequent 
NDRD seen in 40% of the patients overall 
(both Group-I and Group-II). In a study from 
Taiwan, AIN was the most prevalent NDRD 
(46.5%), followed by membranous nephropathy 
and IgA nephropathy.32 An Indian study also 
found AIN to be the most common NDRD, 
found in 18.1% of the patients with mixed 
renal disease (NDRD superimposed on DN), 
while membranous nephropathy (19.2%) was 
the most frequent diagnosis in patients with 
isolated NDRD.16 IgA nephropathy is reported 
to be the most frequent type of NDRD in the 
Chinese, Korean and Japanese population with 
diabetes.23,24,28,40 It is important to keep in mind 
that interstitial inflammatory cell infiltration is 
often prominent in advanced diabetic glome-
rulosclerosis. Thus, it is hard to know whether 
this is secondary to DN or superimposed with 
AIN, particularly when there is no prominent 
eosinophil interstitial infiltration. These tubulo-
interstitial changes in DN are said to be related 
to the renal microvascular alterations characte-
ristic of long-term diabetes, and it is now gene-
rally held that they are due to chronic ische-
mia.41 
  The pathogenesis of NDRD in patients with 
diabetes is not well understood. Whether there 
are common etiologic factors in relation to 
diabetes or it is merely a coincidence is not 
clear. Some authors have suggested that the 
predisposition of DN to superimposed neph-
ritis could be attributed to enhanced exposure 
of antigenic cellular components, triggering 
immune responses.40 Others, however, found 
no difference in the prevalence of NDRD bet-
ween patients with and without diabetes and 
that the co-existence of a different glomerulo-
nephritis in the diabetic kidney may be merely 
coincidental.11,14,42 The renal outcome in diabe-
tic patients with NDRD varies and depends on 
the specific type of non-diabetic renal lesion. 
  We conclude that the prevalence of NDRD, 
either isolated or superimposed on underlying 
DN, is high in diabetics with proteinuria. It is 
recommended that nephrologists maintain a 
high index of suspicion for performing renal 
biopsy in diabetic patients. Early diagnosis of 
NDRD helps in instituting appropriate therapy, 
which in turn could aid in prolonging renal 
survival in this patient population. 
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